<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Valproic acid pathway" Version="20160811" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Valproic acid is a drug used for treatment and management of seizure disorders, mania and prophylactic treatment of migraine headache. In epileptics, valproic acid is used to control absence seizures, tonic-clonic seizures (grand mal), complex partial seizures, and the seizures associated with Lennox-Gastaut syndrome. 
Valproic Acid dissociates to the valproate ion in the gastrointestinal tract and then binds to and inhibits GABA transaminase. The drug's anticonvulsant activity may be related to increased brain concentrations of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the CNS, by inhibiting enzymes that catabolize GABA or block the reuptake of GABA into glia and nerve endings. Valproic Acid may also work by suppressing repetitive neuronal firing through inhibition of voltage-sensitive sodium channels. It is also a histone deacetylase inhibitor. Valproic acid has also been shown to be an inhibitor of an enzyme called histone deacetylase 1 (HDAC1). HDAC1 is needed for HIV to remain in infected cells. A study published in August 2005 revealed that patients treated with valproic acid in addition to highly active antiretroviral therapy (HAART) showed a 75% reduction in latent HIV infection. 
Source: description from http://www.drugbank.ca/drugs/DB00313
Metabolic pathway from: http://smpdb.ca/view/SMP00635

Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP3871 CPTAC Assay Portal].</Comment>
  <BiopaxRef>e87</BiopaxRef>
  <BiopaxRef>e66</BiopaxRef>
  <BiopaxRef>bb2</BiopaxRef>
  <BiopaxRef>e2c</BiopaxRef>
  <BiopaxRef>c6b</BiopaxRef>
  <BiopaxRef>b78</BiopaxRef>
  <BiopaxRef>f67</BiopaxRef>
  <BiopaxRef>cd4</BiopaxRef>
  <BiopaxRef>f5b</BiopaxRef>
  <BiopaxRef>f1a</BiopaxRef>
  <BiopaxRef>c49</BiopaxRef>
  <Graphics BoardWidth="1264.0" BoardHeight="654.0"/>
  <DataNode TextLabel="GABA" GraphId="a44be" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Pentanoyl-CoA" GraphId="a45ef" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="3-Oxovalproic acid" GraphId="a789b" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ACSM1" GraphId="a8ecb" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="2-Propylglutaric acid" GraphId="aa25d" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="3-Hydroxyvalproic acid" GraphId="ad512" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="2-Propyl-2,4-pentadienoic acid" GraphId="ad92e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="HADHB" GraphId="b0c11" Type="GeneProduct" GroupRef="c9f39">
        </DataNode>
  <DataNode TextLabel="3-ene-Valproic acid CoA" GraphId="b12f1" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="4-ene-Valproic acid" GraphId="b3b1f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="UGT1A3" GraphId="b5135" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="2-n-Propyl-4-oxopentanoic acid" GraphId="b7bd3" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="EHHADH" GraphId="bb0d6" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="4-ene-Valproic acid CoA" GraphId="bcd83" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CYP2B6" GraphId="c0fa6" Type="GeneProduct" GroupRef="b3779">
        </DataNode>
  <DataNode TextLabel="2,3-diene-Valproic acid-CoA" GraphId="c2e9e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Propionyl-CoA" GraphId="c3331" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="4-Hydroxyvalproic acid" GraphId="c69e5" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="2,3-diene-Valproic acid-CoA" GraphId="c7ba1" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="HDAC1" GraphId="cb258" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="HSD17B10" GraphId="cc299" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="3-ene-Valproic acid CoA" GraphId="ce0dc" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Uridine 5'-diphosphate" GraphId="d654b" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="3-Hydroxyvalproic acid CoA" GraphId="d9488" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="3-oxo-Valproic acid CoA" GraphId="e4898" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Valproic acid CoA" GraphId="e7872" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="HADHA" GraphId="eae84" Type="GeneProduct" GroupRef="c9f39">
        </DataNode>
  <DataNode TextLabel="2-ene-Valproic acid CoA" GraphId="edb5a" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="5-Hydroxyvalproic acid" GraphId="efe2d" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CYP2A6" GraphId="f14ac" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CYP2C9" GraphId="f21c3" Type="GeneProduct" GroupRef="b3779">
        </DataNode>
  <DataNode TextLabel="ACADSB" GraphId="f42e0" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Valproic acid" GraphId="f5d6c" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="IVD" GraphId="fa5fc" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Uridine diphosphate glucuronic acid" GraphId="fbc9f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ABAT" GraphId="fd19b" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Valproic acid glucuronide" GraphId="ff488" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ACADSB" GraphId="af9f3" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CYP2A6" GraphId="be914" Type="GeneProduct" GroupRef="b3779">
        </DataNode>
  <DataNode TextLabel="CYP2B6" GraphId="e56a9" Type="GeneProduct" GroupRef="f29e5">
        </DataNode>
  <DataNode TextLabel="CYP2C9" GraphId="d9a88" Type="GeneProduct" GroupRef="f29e5">
        </DataNode>
  <DataNode TextLabel="CYP2A6" GraphId="c3ec0" Type="GeneProduct" GroupRef="f29e5">
        </DataNode>
  <Interaction GraphId="id1995c725">
    <Graphics>
      <Point GraphRef="fd19b"/>
      <Point GraphRef="a44be" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id1e633927">
    <Graphics>
      <Point GraphRef="cc299"/>
      <Point GraphRef="d19a3" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2cfa5fb5">
    <Graphics>
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="cb258" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2d02804b">
    <Graphics>
      <Point GraphRef="fa5fc"/>
      <Point GraphRef="bde08" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2f648ebb">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="ad512" ArrowHead="mim-conversion"/>
      <Anchor Position="0.756198347107438" Shape="None" GraphId="b9314"/>
      <Anchor Position="0.7983870967741935" Shape="None" GraphId="b6204"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id4144e0f6">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d9488"/>
      <Point GraphRef="e4898" ArrowHead="mim-conversion"/>
      <Anchor Position="0.45517241379310347" Shape="None" GraphId="d19a3"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id55e9f5ed">
    <Graphics>
      <Point GraphRef="d9488"/>
      <Point GraphRef="a45ef" ArrowHead="mim-conversion"/>
      <Anchor Position="0.6511434511434512" Shape="None" GraphId="a805e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id582061f7">
    <Graphics>
      <Point GraphRef="f42e0"/>
      <Point GraphRef="f4bbd" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5d7d6e91">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="b12f1" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id60644b66">
    <Graphics>
      <Point GraphRef="e7872"/>
      <Point GraphRef="edb5a" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5316455696202531" Shape="None" GraphId="bde08"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id65ba893d">
    <Graphics>
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="fd19b" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id73e3d248">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b3b1f"/>
      <Point/>
      <Point GraphRef="ad92e" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8fa4bd83">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="e7872" ArrowHead="mim-conversion"/>
      <Anchor Position="0.813953488372093" Shape="None" GraphId="be7a7"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id982c5e06">
    <Graphics>
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="b3b1f" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5620437956204379" Shape="None" GraphId="ff4b6"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9a806b06">
    <Graphics>
      <Point GraphRef="f14ac"/>
      <Point GraphRef="b6204" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida3dac828">
    <Graphics>
      <Point GraphRef="efe2d"/>
      <Point GraphRef="aa25d" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idab069254">
    <Graphics>
      <Point GraphRef="ac43b"/>
      <Point GraphRef="fde79" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idae4e4c92">
    <Graphics>
      <Point GraphRef="ac43b"/>
      <Point GraphRef="d9e5e" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb6ab8272">
    <Graphics>
      <Point GraphRef="cd191"/>
      <Point GraphRef="a805e" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbde5e8c5">
    <Graphics>
      <Point GraphRef="a8ecb"/>
      <Point GraphRef="be7a7" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbeebe9d5">
    <Graphics>
      <Point GraphRef="ad512"/>
      <Point GraphRef="a789b" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbfe334c8">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="efe2d" ArrowHead="mim-conversion"/>
      <Anchor Position="0.9165829145728643" Shape="None" GraphId="d9e5e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc199ade6">
    <Graphics>
      <Point GraphRef="edb5a"/>
      <Point GraphRef="d9488" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="b606a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc32b731">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b3b1f"/>
      <Point/>
      <Point GraphRef="bcd83" ArrowHead="mim-conversion"/>
      <Anchor Position="0.6818181818181818" Shape="None" GraphId="f4bbd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc99fbf31">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="ff488" ArrowHead="Arrow"/>
      <Anchor Position="0.7722772277227723" Shape="None" GraphId="eca99"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd181917f">
    <Graphics>
      <Point GraphRef="b5135"/>
      <Point GraphRef="eca99" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd63beb11">
    <Graphics>
      <Point GraphRef="af9f3"/>
      <Point GraphRef="bde08" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idda319cb2">
    <Graphics>
      <Point GraphRef="cd191"/>
      <Point GraphRef="daa96" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide1e0c97c">
    <Graphics ConnectorType="Curved">
      <Point GraphRef="fbc9f"/>
      <Point/>
      <Point GraphRef="d654b" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide2b8bfdf">
    <Graphics>
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="a7bfe" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide5042a65">
    <Graphics>
      <Point GraphRef="fbee4"/>
      <Point GraphRef="ff4b6" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide557227e">
    <Graphics>
      <Point GraphRef="ce0dc"/>
      <Point GraphRef="c7ba1" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ided6fe93b">
    <Graphics>
      <Point GraphRef="bcd83"/>
      <Point GraphRef="c2e9e" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf3769eec">
    <Graphics>
      <Point GraphRef="edb5a"/>
      <Point GraphRef="ce0dc" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf63499af">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f5d6c"/>
      <Point GraphRef="c69e5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.8527272727272728" Shape="None" GraphId="fde79"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfe66c80d">
    <Graphics>
      <Point GraphRef="bb0d6"/>
      <Point GraphRef="b606a" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idffad02b4">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d9488"/>
      <Point GraphRef="c3331" ArrowHead="mim-conversion"/>
      <Anchor Position="0.52" Shape="None" GraphId="daa96"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="re-uptake &#10;of GABA" GraphId="a7bfe">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="increased levels" GraphId="c255c">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="metabolism" GraphId="d164a">
    <Graphics FillColor="ffff00" ShapeType="Rectangle" Color="333333"/>
  </Label>
  <Label TextLabel="mode of action" GraphId="d5ce5">
    <Graphics FillColor="ffff00" ShapeType="Rectangle"/>
  </Label>
  <Group GroupId="f29e5" GraphId="ac43b" Style="Group"/>
  <Group GroupId="c9f39" GraphId="cd191" Style="Complex"/>
  <Group GroupId="e3d47" GraphId="d7d49" Style="Group"/>
  <Group GroupId="b3779" GraphId="fbee4" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2c">
      <bp:ID >1988037</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitochondrial metabolism of valproic acid.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Li J</bp:AUTHORS>
      <bp:AUTHORS >Norwood DL</bp:AUTHORS>
      <bp:AUTHORS >Mao LF</bp:AUTHORS>
      <bp:AUTHORS >Schulz H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b78">
      <bp:ID >14597963</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes.</bp:TITLE>
      <bp:SOURCE >Pharmacogenomics J</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Ho PC</bp:AUTHORS>
      <bp:AUTHORS >Abbott FS</bp:AUTHORS>
      <bp:AUTHORS >Zanger UM</bp:AUTHORS>
      <bp:AUTHORS >Chang TK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >epilepsy</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:1826</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c6b">
      <bp:ID >2112956</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1990</bp:YEAR>
      <bp:AUTHORS >Ito M</bp:AUTHORS>
      <bp:AUTHORS >Ikeda Y</bp:AUTHORS>
      <bp:AUTHORS >Arnez JG</bp:AUTHORS>
      <bp:AUTHORS >Finocchiaro G</bp:AUTHORS>
      <bp:AUTHORS >Tanaka K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f5b">
      <bp:ID >17687269</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects.</bp:TITLE>
      <bp:SOURCE >Clin Pharmacol Ther</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Chung JY</bp:AUTHORS>
      <bp:AUTHORS >Cho JY</bp:AUTHORS>
      <bp:AUTHORS >Yu KS</bp:AUTHORS>
      <bp:AUTHORS >Kim JR</bp:AUTHORS>
      <bp:AUTHORS >Lim KS</bp:AUTHORS>
      <bp:AUTHORS >Sohn DR</bp:AUTHORS>
      <bp:AUTHORS >Shin SG</bp:AUTHORS>
      <bp:AUTHORS >Jang IJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f67">
      <bp:ID >16945988</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.</bp:TITLE>
      <bp:SOURCE >Toxicol Sci</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Kiang TK</bp:AUTHORS>
      <bp:AUTHORS >Ho PC</bp:AUTHORS>
      <bp:AUTHORS >Anari MR</bp:AUTHORS>
      <bp:AUTHORS >Tong V</bp:AUTHORS>
      <bp:AUTHORS >Abbott FS</bp:AUTHORS>
      <bp:AUTHORS >Chang TK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >xenobiotic metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001229</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd4">
      <bp:ID >9353388</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid.</bp:TITLE>
      <bp:SOURCE >J Pharmacol Exp Ther</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Sadeque AJ</bp:AUTHORS>
      <bp:AUTHORS >Fisher MB</bp:AUTHORS>
      <bp:AUTHORS >Korzekwa KR</bp:AUTHORS>
      <bp:AUTHORS >Gonzalez FJ</bp:AUTHORS>
      <bp:AUTHORS >Rettie AE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f1a">
      <bp:ID >18838507</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Argikar UA</bp:AUTHORS>
      <bp:AUTHORS >Remmel RP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >neuron</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000540</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e87">
      <bp:ID >8168173</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes.</bp:TITLE>
      <bp:SOURCE >Chem Biol Interact</bp:SOURCE>
      <bp:YEAR >1994</bp:YEAR>
      <bp:AUTHORS >Kassahun K</bp:AUTHORS>
      <bp:AUTHORS >Hu P</bp:AUTHORS>
      <bp:AUTHORS >Grillo MP</bp:AUTHORS>
      <bp:AUTHORS >Davis MR</bp:AUTHORS>
      <bp:AUTHORS >Jin L</bp:AUTHORS>
      <bp:AUTHORS >Baillie TA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e66">
      <bp:ID >1676665</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Kassahun K</bp:AUTHORS>
      <bp:AUTHORS >Farrell K</bp:AUTHORS>
      <bp:AUTHORS >Abbott F</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c49">
      <bp:ID >15761113</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >valproic acid drug pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001451</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >hepatocyte</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000182</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb2">
      <bp:ID >21843514</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Valproic acid utilizes the isoleucine breakdown pathway for its complete &#206;&#178;-oxidation.</bp:TITLE>
      <bp:SOURCE >Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR >2011</bp:YEAR>
      <bp:AUTHORS >Lu&#195;&#173;s PB</bp:AUTHORS>
      <bp:AUTHORS >Ruiter JP</bp:AUTHORS>
      <bp:AUTHORS >Ofman R</bp:AUTHORS>
      <bp:AUTHORS >Ijlst L</bp:AUTHORS>
      <bp:AUTHORS >Moedas M</bp:AUTHORS>
      <bp:AUTHORS >Diogo L</bp:AUTHORS>
      <bp:AUTHORS >Garcia P</bp:AUTHORS>
      <bp:AUTHORS >de Almeida IT</bp:AUTHORS>
      <bp:AUTHORS >Duran M</bp:AUTHORS>
      <bp:AUTHORS >Wanders RJ</bp:AUTHORS>
      <bp:AUTHORS >Silva MF</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>